期刊文献+

硫辛酸联合依帕司他治疗老年2型糖尿病周围神经病变70例疗效观察 被引量:5

下载PDF
导出
摘要 目的:观察硫辛酸联合依帕司他治疗老年2型糖尿病周围神经病变的临床疗效。方法:70例2型糖尿病周围神经病变患者随机分为两组,对照组采用甲钴胺注射液治疗,治疗组用硫辛酸联合依帕司他注射液静脉输注,疗程均为3周。结果:2型糖尿病周围神经病变症状及神经传导速度均有明显改善,但治疗组比对照组改善明显(P<0.05)。结论:硫辛酸联合依帕司他治疗老年2型糖尿病周围神经病变疗效优于对照组,能够明显改善老年2型糖尿病周围神经病变患者的临床症状及神经传导速度。 Objective To observe the lipoic acid joint epalrestat treatment of elderly type 2 diabetic peripheral neuropathy clinical efficacy. Methods 70 cases of type 2 diabetic peripheral neuropathy patients were randomly divided into two groups, control group Methylcobalamin Injection treatment, treatment group using lipoic acid joint epalrestat injection by intravenous infusion, a course of three weeks. Results Type 2 diabetic peripheral neuropathy symptoms and nerve conduction speed obviously improved, but the treatment group improved significantly compared with the control group ( P 〈 0. 05). Conclusion lipoic acid than the control group, significant improvement in elderly type 2 diabetic peripheral nerve lesions in patients with clinical symptoms and nerve conduction velocity joint according to Pascal treatment of elderly type 2 diabetic peripheral neuropathy.
出处 《内蒙古中医药》 2013年第28期4-5,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
关键词 硫辛酸注射液 依帕司他 老年2型糖尿病 周围神经病变 lipoic acid injection fluid epalrestat elderly type 2 diabetes peripheral neuropathy
  • 相关文献

参考文献5

  • 1陈新谦 金有豫.新编药物学[M].北京:人民卫生出版社,1998.113-114.
  • 2Vinik AI.Diabetic neuropathy:pathogenesis and therapy[J].Am JMed,1999,107 (2B):17-26.
  • 3Ikeda T,Iwata K,Tanaka Y.Long-term effect of epalrestat on cardiac autonomic neuropathy in subjects with non-insulin dependent diabetes mellitus[J].DiabetesResClin Pract,1999,43 (3):193-198.
  • 4Hamada Y,Nakamura J,Naruse K,et al.Epalrestat,an aldose reductase inhibitor,reduces the levels of Nepsilon-(carboxymethyl) lysine protein adducts and their precursors in erythrocytes from diabetic patients[J].Diabetes Care,2000,23 (10):1539-1544.
  • 5钱巧慧,冯波,孙梅.α-硫辛酸对2型糖尿病氧化应激状态和内皮功能的影响[J].临床内科杂志,2006,23(9):600-601. 被引量:30

二级参考文献5

  • 1冯波,陈琳,黄云洲.糖尿病患者内皮tPA、NO储备与血管舒张功能变化[J].中华内分泌代谢杂志,2004,20(5):432-434. 被引量:10
  • 2Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature,2001,414:813-820.
  • 3Ziegler D, Hanefold M, Ruhnan Kj,et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid: a 3-week multicentre randomized controlled trial(ALADIN study). Diabetologia, 1995,38 : 1425-1433.
  • 4Da Ros R, Assaloni R,Ceriello A. Molecular targets of diabetic vascular complications and potential new drugs. Curr Drug Targets,2005,6:503-509.
  • 5Yorek MA, Coppey LJ, Gellett .IS, et al. Effect of fidarestat and alpha-lipoic acid on diabetes-induced epineurial arteriole vascular dysfunction.Exp Diabesity Res ,2004,5 : 123-135.

共引文献142

同被引文献35

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部